Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Advanced Statistics in Regulatory Critical Clinical Initiatives (Chapman & Hall
Type
Physical Book
Publisher
Language
English
Pages
307
Format
Hardcover
ISBN13
9780367561789
Edition No.
1

Advanced Statistics in Regulatory Critical Clinical Initiatives (Chapman & Hall

Wei Zhang, Fangrong Yan, Feng Chen, Shein-Chung Chow (Author) · Crc Pr Inc · Hardcover

Advanced Statistics in Regulatory Critical Clinical Initiatives (Chapman & Hall - Wei Zhang, Fangrong Yan, Feng Chen, Shein-Chung Chow

Physical Book

£ 135.00

£ 150.00

You save: £ 15.00

10% discount
  • Condition: New
It will be shipped from our warehouse between Tuesday, June 11 and Friday, June 14.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Advanced Statistics in Regulatory Critical Clinical Initiatives (Chapman & Hall"

Advanced Statistics in Regulatory Critical Clinical Initiatives is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development. Advanced Statistics in Regulatory Critical Clinical Initiatives provides innovative ways to resolve common challenges in statistical research of rare diseases such small sample sizes and provides guidance for combined use of data. With analysis from regulatory and scientific perspectives this book is an ideal companion for researchers in biostatistics, pharmaceutical development, and policy makers in related fields.Key Features: Provides better understanding of innovative design and analysis of each critical clinical initiatives which may be used in regulatory review/approval of drug development. Makes recommendations to evaluate submissions accurately and reliably. Proposes innovative study designs and statistical methods for oncology and/or rare disease drug development. Provides insight regarding current regulatory guidance on drug development such as gene therapy and rare diseases.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews